In response to the Bayer Phillips’ Colon Health case, the dietary supplement industry says the agency’s substantiation bar is too high.
But questionable antiaging and diabetes claims are also on the rise.
Two industry leaders offer advice to the next head of FDA’s Division of Dietary Supplements—whoever she or he may be.
It's not FTC action alone.
Overall, the study results were largely inconclusive against disease prevention.
Has FDA effectively slammed the door shut on DMAA?
Will a new, negative Department of Health and Human Services report follow the dietary supplements industry for years?
Recently ramped-up enforcement against synthetic botanicals means FDA needs to readdress synthetic botanicals in the draft guidance even before revising other parts, CRN wrote.
One of the reports, on structure-function claims, reports finding dubious claims on numerous products.
By developing proper SOPs for laboratory qualification, industry can hopefully work to eliminate the problem of "dry labbing" altogether.
Join the Nutra-Q Suppliers Directory! Be a part of the industry's only qualified database of suppliers.
© 2014 NutritionalOutlook.com